Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors

Clinical trial NCT02780804 · COMPLETED

Trial details

NCT number: NCT02780804
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain Stem Neoplasm Pineal Region Neoplasm Recurrent Lymphoma Recurrent Malignant Solid Neoplasm Recurrent Primary Central Nervous System Neoplasm Recurrent Visual Pathway Glioma Refractory Lymphoma Refractory Malignant Solid Neoplasm Refractory Primary Central Nervous System Neoplasm Refractory Visual Pathway Glioma

Start date: 2017-01-06
Primary completion: 2021-06-30
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.